Literature DB >> 22549745

Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

Charlotte Angerstein1, Michael Hecker, Brigitte Katrin Paap, Dirk Koczan, Madhan Thamilarasan, Hans-Jürgen Thiesen, Uwe Klaus Zettl.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs which regulate many genes post-transcriptionally. In various contexts of medical science, miRNAs gained increasing attention over the last few years. Analyzing the functions, interactions and cellular effects of miRNAs is a very complex and challenging task. Many miRNA databases with diverse data contents have been developed. Here, we demonstrate how to integrate their information in a reasonable way on a set of miRNAs that were found to be dysregulated in the blood of patients with multiple sclerosis (MS). Using the miR2Disease database, we retrieved 16 miRNAs associated with MS according to four different studies. We studied the predicted and experimentally validated target genes of these miRNAs, their expression profiles in different blood cell types and brain tissues, the pathways and biological processes affected by these miRNAs as well as their regulation by transcription factors. Only miRNA-mRNA interactions that were predicted by at least seven different prediction algorithms were considered. This resulted in a network of 1,498 target genes. In this network, the MS-associated miRNAs hsa-miR-20a-5p and hsa-miR-20b-5p occurred as central hubs regulating about 500 genes each. Strikingly, many of the putative target genes play a role in T cell activation and signaling, and many have transcription factor activity. The latter suggests that miRNAs often act as regulators of regulators with many secondary effects on gene expression. Our present work provides a guideline on how information of different databases can be integrated in the analysis of miRNAs. Future investigations of miRNAs shall help to better understand the mechanisms underlying different diseases and their treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549745     DOI: 10.1007/s12035-012-8270-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  127 in total

1.  miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients.

Authors:  Julio Cesar Cetrulo Lorenzi; Doralina G Brum; Dalila L Zanette; Alessandra de Paula Alves Souza; Fernanda Gonçalves Barbuzano; Antonio Carlos Dos Santos; Amilton Antunes Barreira; Wilson Araujo da Silva
Journal:  Int J Neurosci       Date:  2012-05-01       Impact factor: 2.292

Review 2.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

4.  Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells.

Authors:  Fuping Zhang; Guangxun Meng; Warren Strober
Journal:  Nat Immunol       Date:  2008-10-12       Impact factor: 25.606

5.  Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Authors:  P Rieckmann; M Albrecht; B Kitze; T Weber; H Tumani; A Broocks; W Lüer; A Helwig; S Poser
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

6.  Multiple sclerosis immunology: The healthy immune system vs the MS immune system.

Authors:  Lloyd H Kasper; Jennifer Shoemaker
Journal:  Neurology       Date:  2010-01-05       Impact factor: 9.910

7.  starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.

Authors:  Jian-Hua Yang; Jun-Hao Li; Peng Shao; Hui Zhou; Yue-Qin Chen; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

8.  microRNA target predictions across seven Drosophila species and comparison to mammalian targets.

Authors:  Dominic Grün; Yi-Lu Wang; David Langenberger; Kristin C Gunsalus; Nikolaus Rajewsky
Journal:  PLoS Comput Biol       Date:  2005-06-24       Impact factor: 4.475

9.  Differential micro RNA expression in PBMC from multiple sclerosis patients.

Authors:  David Otaegui; Sergio E Baranzini; Ruben Armañanzas; Borja Calvo; Maider Muñoz-Culla; Puya Khankhanian; Iñaki Inza; Jose A Lozano; Tamara Castillo-Triviño; Ana Asensio; Javier Olaskoaga; Adolfo López de Munain
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

10.  The database of experimentally supported targets: a functional update of TarBase.

Authors:  Giorgos L Papadopoulos; Martin Reczko; Victor A Simossis; Praveen Sethupathy; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2008-10-27       Impact factor: 16.971

View more
  25 in total

1.  Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine-1-phosphate receptor modulator.

Authors:  Ines C Angerer; Michael Hecker; Dirk Koczan; Luisa Roch; Jörg Friess; Annelen Rüge; Brit Fitzner; Nina Boxberger; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Alexander Winkelmann; Stefanie Meister; Uwe K Zettl
Journal:  CNS Neurosci Ther       Date:  2018-01-03       Impact factor: 5.243

Review 2.  MicroRNAs in neuronal communication.

Authors:  Guilherme Shigueto Vilar Higa; Erica de Sousa; Lais Takata Walter; Erika Reime Kinjo; Rodrigo Ribeiro Resende; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

3.  MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.

Authors:  Francesca De Vito; Alessandra Musella; Diego Fresegna; Francesca Romana Rizzo; Antonietta Gentile; Mario Stampanoni Bassi; Luana Gilio; Fabio Buttari; Claudio Procaccini; Alessandra Colamatteo; Silvia Bullitta; Livia Guadalupi; Silvia Caioli; Valentina Vanni; Sara Balletta; Krizia Sanna; Antonio Bruno; Ettore Dolcetti; Roberto Furlan; Annamaria Finardi; Valerio Licursi; Jelena Drulovic; Tatjana Pekmezovic; Clorinda Fusco; Sara Bruzzaniti; Eran Hornstein; Antonio Uccelli; Marco Salvetti; Giuseppe Matarese; Diego Centonze; Georgia Mandolesi
Journal:  Neuropathol Appl Neurobiol       Date:  2021-10-06       Impact factor: 6.250

4.  Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.

Authors:  William J Magner; Bianca Weinstock-Guttman; Mina Rho; David Hojnacki; Rabia Ghazi; Murali Ramanathan; Thomas B Tomasi
Journal:  J Neuroimmunol       Date:  2016-01-21       Impact factor: 3.478

5.  Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.

Authors:  Michael Hecker; Christiane Hartmann; Ole Kandulski; Brigitte Katrin Paap; Dirk Koczan; Hans-Juergen Thiesen; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2013-05-01       Impact factor: 5.590

6.  Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.

Authors:  Harsh Dweep; Carsten Sticht; Asawari Kharkar; Priyanka Pandey; Norbert Gretz
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

7.  Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.

Authors:  Lilach Soreq; Nathan Salomonis; Michal Bronstein; David S Greenberg; Zvi Israel; Hagai Bergman; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-05-13       Impact factor: 5.639

8.  In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions.

Authors:  Harsh Dweep; Carsten Sticht; Norbert Gretz
Journal:  Curr Genomics       Date:  2013-04       Impact factor: 2.236

9.  Molecular network analysis of human microRNA targetome: from cancers to Alzheimer's disease.

Authors:  Jun-Ichi Satoh
Journal:  BioData Min       Date:  2012-10-03       Impact factor: 2.522

10.  MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients.

Authors:  Michael Hecker; Madhan Thamilarasan; Dirk Koczan; Ina Schröder; Kristin Flechtner; Sherry Freiesleben; Georg Füllen; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.